CSLLY News and Press, CSL Ltd ADR From 05/13/22

Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. Over the first quarter of 2022, the Polen International Growth Composite Portfolio returned -13.94% gross and -14.17% net of fees, res...

Walter Charles Named Senior Vice President and General Manager of CSL Plasma PR Newswire Charles will lead global organization in the collection of plasma that is used by CSL Behring to manufacture life-saving therapies for patients around the world BOCA RATO...

CSL Behring Donates 500 Million International Units of Coagulation Factor Replacement Therapy to the World Federation of Hemophilia Humanitarian Aid Program to Help Those Living with Bleeding Disorders PR Newswire The 500 million international units (IUs) will include pr...

European Medicines Agency Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B PR Newswire Marketing Authorization Application (MAA) for etranacogene dezaparvovec will be reviewed under accelerated assessment and has the...

Shares of Haemonetics (HAE -5.5%) are down in late afternoon trading after the FDA approved Terumo Blood and Cell Technologies' Rika Plasma Donation System. Rika will be used by CSL Plasma, the plasma collection business of CSL Limited (OTCPK:CSLLY +1.8%), a rival of Haemonetics (HAE -5.5%). ...

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220307005938/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology...

Sanofi (SNY -0.0%) has filed a Citizen Petition with the FDA asking the agency to change the labeling of Seqirus' Fluad flu vaccines as a confirmatory post-market study failed to confirm clinical benefit. The Fluad vaccine was approved under the FDA's accelerated approval pathway in 2015. Tha...

Forbes Magazine Ranks Global Biotech Leader CSL Among America's Best Employers for 2022 With 25,000 global employees, CSL is one of 500 Large Employers recognized across 25 industry sectors PR Newswire KING OF PRUSSIA, Pa. , March 2, 2022 /PRNewswire/ -- ...

Seqirus and U.S. Government Renew Multi-Year Agreement for Influenza Pandemic Preparedness and Response - Renewal reaffirms longstanding, public-private partnership between Seqirus and the Biomedical Advanced Research and Development Authority (BARDA) to strengthen preparedness ...

CSL Plasma Makes $125,000 Donation to American Red Cross for Disaster Relief in U.S. Communities Donation supports local relief and recovery in communities impacted by 60,000+ natural disasters and emergencies that happen each year PR Newswire BOCA RATON, Fla. , ...